Astellas, Adaptimmune to develop CAR-T & TCR T-cell therapies

Japan |  News | 0 Comment | 17 Jan, 2020

Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, have announced that t...Read more

ASKA, KinoPharma unite to treat cervical dysplasia

Japan |  News | 0 Comment | 16 Jan, 2020

ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into an option agreement for an exclusive license for the development and...Read more

Hitachi starts commercial manufacturing of Zynteglo

Japan |  News | 0 Comment | 15 Jan, 2020

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manufacturing of cell and gene therapeutics, starts the commercial manufa...Read more

ERS Genomics licenses CRISPR gene editing technology to Daiichi Sankyo

Japan |  News | 0 Comment | 14 Jan, 2020

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, has announced the signing of a l...Read more

FDA approves sNDA for Astellas’s antifungal drug

Japan |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for MYCAMINE® (micafungin ...Read more

Chugai signs licensing deal with Verastem for cancer drug

Japan |  News | 0 Comment | 10 Jan, 2020

Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreement with Verastem Oncology  regarding CKI27 (CH5126766), an inve...Read more

Huya Bioscience ropes in Meiji as distributor for Asian region

Japan |  News | 0 Comment | 10 Jan, 2020

US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointment of Japanese firm Meiji Seika Pharma (Meiji) as an exclusive distr...Read more

Alma receives excellence award in Japan

Japan |  News | 0 Comment | 09 Jan, 2020

Alma, a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and surgical markets, has been recognized with an Excellence Award for...Read more

Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

Japan |  News | 0 Comment | 07 Jan, 2020

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and Japan based NEC Corporation, a leader in IT and network techn...Read more

aTyr Pharma, Kyorin to work on interstitial lung diseases

Japan |  News | 0 Comment | 07 Jan, 2020

US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, has announced that it has enter...Read more

Urovant inks $300M loan agreement with Sumitomo Pharma

Japan |  News | 0 Comment | 02 Jan, 2020

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term loan facility with Sumitomo Dainippon Pharma, a leading global Japanes...Read more

Japan develops new tumour-on-a-chip device

Japan |  News | 0 Comment | 01 Jan, 2020

Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside the body, paving the way for improved screening of potential cancer f...Read more

Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Japan |  News | 0 Comment | 16 Dec, 2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "...Read more

Daiichi Sankyo unveils drug for treating colorectal cancer

Japan |  News | 0 Comment | 31 Dec, 2019

Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusions 100 mg and 400 mg “Daiichi Sankyo” (generic name: bev...Read more

Pentax Medical Remains Committed to Endoscopic Ultrasound Business

Japan |  News | 0 Comment | 19 Dec, 2019

PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscopy portfolio. The recent launch of the PENTAX Medical EUS/EBUS-J10* li...Read more

Astellas strengthens immuno-oncology portfolio by acquiring Xyphos

Japan |  News | 0 Comment | 27 Dec, 2019

Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acquired Xyphos. With the acquisition Astellas will gain Xyphos' novel a...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Japan |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody drug con...Read more

Gilead, Eisai to co-promote drug in Japan for RA treatment

Japan |  News | 0 Comment | 26 Dec, 2019

Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreement for the distribution and co-promotion of filgotinib, an investiga...Read more